opensafely/covid-identification/2020-06-03
opensafely/type-2-diabetes/2020-06-29
opensafely/ethnicity/2020-04-27
opensafely/insulin-medication/2020-04-26
opensafely/smoking-clear/2020-04-29
opensafely/type-1-diabetes/2020-06-29
opensafely/type-2-diabetes/2020-06-29
opensafely/diabetes-unknown-type/2020-06-29
opensafely/type-1-diabetes-secondary-care/2020-09-27
opensafely/antidiabetic-drugs/2020-07-16
user/john-tazare/dpp-inhibitors-dmd/61f3a68b
user/john-tazare/metformin-dmd/48e43356
user/john-tazare/sglt2-inhibitors-dmd/2fd4c021
user/john-tazare/sulfonylureas-dmd/16c54cec
opensafely/hypertension/2020-04-28
opensafely/hypertension/2020-04-28
opensafely/aplastic-anaemia/2020-04-24
opensafely/asplenia/2020-06-02
opensafely/cancer-excluding-lung-and-haematological/2020-04-15
opensafely/chemotherapy-or-radiotherapy-updated/2020-04-15
opensafely/chronic-cardiac-disease/2020-04-08
opensafely/chronic-liver-disease/2020-06-02
opensafely/chronic-respiratory-disease/2020-04-10
opensafely/dementia-complete/48c76cf8
opensafely/gi-bleed-or-ulcer/2020-04-08
opensafely/haematological-cancer/2020-04-15
opensafely/hiv/2020-07-13
opensafely/inflammatory-bowel-disease/2020-04-07
opensafely/lung-cancer/2020-04-15
opensafely/other-neurological-conditions/2020-06-02
opensafely/permanent-immunosuppression/2020-06-02
opensafely/ra-sle-psoriasis/2020-04-14
opensafely/sickle-cell-disease/2020-04-14
opensafely/solid-organ-transplantation/2020-04-10
opensafely/temporary-immunosuppression/2020-04-24